BlackRock Fund Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

BlackRock Fund Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-851,430	Closed	-$25.7M	–	4341
2016 Q2	$25.7M	Buy	851,430 +790,309	+1,293%	+$16M	0.01%	1902
2016 Q1	$674K	Sell	61,121 -4,870	-7%	-$16K	﹤0.01%	3211
2015 Q4	$116K	Buy	65,991 +2,043	+3%	+$3.5K	﹤0.01%	3702
2015 Q3	$106K	Sell	63,948 -1,692	-3%	-$3.75K	﹤0.01%	3689
2015 Q2	$147K	Buy	65,640 +7,914	+14%	+$17.9K	﹤0.01%	3640
2015 Q1	$143K	Buy	+57,726	New	+$155K	﹤0.01%	3564

BlackRock Fund Advisors's CPXX Position: Q3 2016 in Review

BlackRock Fund Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 851,430 shares — an estimated $25.7M sold.

BlackRock Fund Advisors first reported a position in CPXX in Q1 2015 and held it in 6 quarters. The position peaked at $25.7M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

BlackRock Fund Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 851,430 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $25.7M.
BlackRock Fund Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2015 and held it in 6 quarters.
BlackRock Fund Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $25.7M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on BlackRock Fund Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.